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INTRODUCTION 
In previous reports (Christensen, 1944, 1945) evidence has been presented which 
indicates that the lysin factor of Milstone (1941) is an inactive proteolytic enzyme of 
serum which may be activated by streptococcal fibrinolysin,  and that the activation is 
apparently catalytic in nature.  It has also been shown that proteolysis by this acti- 
vated enzyme is responsible for the phenomenon of streptococcal fibrinolysis. 
Dastre (1893) originally drew attention to the proteolytic activity of serum, and a 
few years later Delezene and Pozerski (1903) reported that serum could be rendered 
proteolytic  by  treatment  with  chloroform.  Since  that  time,  many  reports  have 
appeared  dealing  with  this  chloroform-activated serum  protease.  In  a  series  of 
recent papers, Tagnon and  his  coworkers  (1942 b,  c)  have reviewed much of  the 
literature.  The  senma  protease may also be  activated  by other  means,  such  as 
treatment with organic solvents or dialysis (¥amalmwa, 1918), acid precipitation of 
the serum (Opie and Barker, 1908), and by treatment with cerain organic compounds 
such as urea, benzoate, thiocyanate (Jtihling and W6hlisch,  1938), and cresols (Pope, 
1938).  The r61e of the serum protease in blood coagulation has been investigated 
by Ferguson (1939, 1940) and. by Taguon (1942 a, b, c, d). 
Delezene and Pozerski (1903) observed that serum contains two opposing elements, 
the chloroform-activated protease, and an inhibitor of proteases, first described  by 
Hildebra~dt  (cited  by  Opie,  1922).  They  were  led  to the conclusion  that serum 
protease is normally inactive because of the action of the serum inhibitor, and that 
the function  of the  chloroform is to free the protease from it.  The concept that 
serum protease becomes active because of the removal or inactivation of inhibitor 
has been held by several investigators.  Yamakawa (1918) for example, suggested that 
the  activation  of  serum protease upon  treatment with  organic solvents is due  to 
removal of the inhibitor, a conclusion supported by the work of Teale and Bach (1919) 
who showed that inhibitor is removed from serum as denaturation of the serum pro- 
teins takes place.  Schmitz (1937) interpreted the increase in activity which he noted 
when serum extracts were treated with alumina gel or dialyzed in dilute acetic acid to 
be due to the splitting of the inhibitor-enzyme complex, the inhibitor being adsorbable, 
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States Army, Preventive Medicine  Service,  Office of the  Surgeon  General,  United 
States  Army. 
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acid-soluble,  and  dialyzable.  Jtihling  and  W6hlisch  (1938)  concluded  that  the 
fibrinolysis which follows treatment of plasma with urea is due to removal of the in- 
hibitor by urea.  The literature on the serum inhibitor of proteases has been reviewed 
by Opie (1922)  and by Grob (1943). 
Schmitz (1938), employing the method used by Kunitz and Northrop (1936), isolated 
a small amount of inhibitor from serum which appeared to be similar to, if not identical 
with the crystalline trypsin inhibitor isolated by the latter workers from the pancreas. 
There are certain similarities between fibrinolysin-activated lysln factor and chloro- 
form-activated serum  protease  (Christensen,  1944,  1945;  Kaplan,  1944).  For  ex- 
ample both are present in the euglobulin fraction of serum, both are present as inactive 
precursors which must be activated, and both are active against a variety of  proteins 
at  neutral  pH. 
Despite the similarities between chloroform-activated  serum protease and fibrinolysin 
activated  lysin  factor,  one  striking  difference  may  be  noted.  Activation  of  the 
serum protease by any of the recommended methods appears to be a relatively slow 
process, whereas in the presence of an excess of fibrinolysin, lysin factor is activated 
almost instantaneously.  These obserwtions have been confirmed recently by Kaplan 
(1944). 
The data obtained in the present study indicate that the protease activated 
by chloroform and that activated by fibrinolysin are one and the same enzyme. 
It is also shown that the protease is not inactive because of combination with 
inhibitor, but because it is in an inactive, precursor state from which it can be 
activated by streptococcal fibrinolysifi in a manner analogous to the activation 
of trypsinogen by enterokinase or the mold kinase of Kunitz (1938).  Following 
activation, the active enzyme may be inhibited by serum inhibitor or crystalline 
trypsin inhibitor obtained from the pancreas.  This inactivation,  however, is 
not  influenced  by fibrinolysin.  The  characteristics  of the  serum  enzyme as 
determined in the present study indicate that the protease is not identical with 
pancreatic  trypsin. 
Methods and Materials 
1. The preparation and partial purification of streptococcal fibrinolysin concentrates 
have been described in detail in a previous paper (Christensen,  1945).  The concen- 
trated fibrinolysin solutions used in the present  study represent  a  200-  to 300-fold 
concentration of a  culture supernatant. 
2. The method of determining proteolytic activity has been described in detail in a 
previous paper (Christensen,  1945).  The proteolytic unit used in the present paper 
is defined as the amount of protease which will cause a decrease of 1 per cent per minute 
in the specific viscosity of the reaction mixture of gelatin and enzyme.  The rate of 
viscosity drop is linear for about the first 10 to 15 minutes and is directly proportional 
to the enzyme concentration over the ranges used in this study. 
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inhibitor were prepared by dialyzing human serum 1 for 1 to 2 days against running 
tap water, followed by dilution with 2 volumes of distilled water.  Upon acidification 
to  pH  5.0-5.5  with  acetic acid  a  flocculent precipitate  quickly  settled  out.  The 
precipitate was collected by centrifugation and dissolved in a volume of saline buffer 
at pH 7.4 equal to  ~  the original serum volume. 
4. Activated Lysin Factor.--One  volume of concentrated lysin factor solution was 
mixed with  1 volume of 1 : 10 dilution of concentrated fibrlnolysin and incubated at 
37°C. for 10 minutes.  Under these conditions all of the proteolytic activity of the lysin 
factor is liberated within the first few minutes.  The activated lysin factor solutions 
are stable for several hours at room temperature and for much longer periods in the 
refrigerator.  However, in the majority of the experiments reported in the present 
paper,  lysin factor was activated immediately before use. 
5.  Serum  Proteaze.--The  method  employed  was  essentially  that  described  by 
Tagnon  (1942 b),  a  modification of the process devised by Delezene and  Pozerski 
(1903).  With lots of plasma of 50 to 100 ml., fairly consistent results were obtained. 
When the same method was used with  1 to 5 liter quantities of plasma, however, 
activation was not obtained consistently, and not more than 25 to 50 per cent of the 
preparations showed sufficient activity to be useable.  The details of the preparative 
procedure were as follows: Plasma  1 was shaken with 3~ volume of chloroform for 2 
minutes.  A fibrin clot formed within a few hours and dissolved again within 24 to 36 
hours, although in some cases a  longer time was required.  The majority of active 
preparations were obtained by Iractionation of the material 2 to 4 days after disappear- 
ance of the fibrin clot, although in one instance activity did not develop for more than 
a  week.  The chloroform-serum mixture was centrifuged for 1 to 2 hours and  the 
supernatant decanted from the mixture of chloroform and denatured proteins.  The 
supernatant was then treated exactly as in the method for the preparation of lysin 
factor, namely, acidification to pH 5.0-5.5 of the dialyzed and diluted material.  The 
precipitate was dissolved in saline buffer in a  volume equivalent to T~- the original 
plasma volume at pH  7.4. 
It is evident from the foregoing that lysin factor and serum protease are present 
in the same fraction of serum, the euglobulin. 
5.  Crystalline Trypsin2.--The sample of  crystalline trypsin  contained  about  50 
per cent magnesium sulfate.  A solution containing 1.0 rag. per ml. of the dry material 
was made up in 0.052 HC1.  Solutions of the concentration desired for testing were 
made up immediately before use in saline buffer and adjusted to pH 7.4. 
7.  Crystalline Trypsin InhibitorS.--The crystalline inhibitor preparation contained 
about 50 per cent magnesium sulfate.  The dry material was dissolved in saline buffer, 
1 The majority of the human plasma used in the present study was made available 
by the Blood Donor Service of the New York Chapter of the American Red Cross. 
It represented for the most part samples of whole blood which could not be used by 
the Donor Service because of positive serology, a short collection, or because it was of 
a  type not suitable for whole blood transfusion. 
2 The crystalline trypsin was supplied through the kindness of Dr. J. S. Fruton. 
3 The crysalline trypsin inhibitor was supplied through the kindness of Dr. J. H. 
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pH 7.4, in a  concentration of 1.0 mg. per ml.  This stock solution  is stable in the 
refrigerator for a  week or more.  Before use,  dilutions  were made to the required 
concentration in saline  buffer. 
8.  Serum Inhibitor  Solution.--Landsteiner  (1900) and  others  (Hedin,  1904-O5; 
Opie and Barker, 1907; Hussey and Northrop, 1923) have shown that the inhibitory 
activity of serum against protcases is  associated with  the  albumin fraction.  The 
serum  inhibitor used in these experiments consisted  of  a  twofold concentration of 
the albumin fraction of pooled human sera, partially purified  by several reprecipita- 
tions followed by dialysis.  The final solution  was made up in saline buffer, pH 7.4. 
9.  Quantitative Estimation of Serum Inhibitor.--Grob (1943) has employed a method 
for the estimation of serum inhibitor based on its ability to inhibit the tryptic digestion 
of casein.  In the present study serum inhibitor was measured by comparing the 
inhibitory action of the serum sample and a standard preparation of crystalline trypsin 
inhibitor on the tryptic digestion  of gelatin.  A standard inhibition curve was pre- 
pared by mixing 0.5 ml. of solutions containing varying amounts of a standard crystal- 
line  trypsin inhibitor solution  with 0.5  ml. of a  solution of a  standard  crystalline 
trypsin solution  containing 0.01 rag.  per ml.  The mixtures were incubated for 15 
minutes and  the residual  proteolytic activity determined  by the method used  for 
the determination of serum protease activity.  When the logarithm of the residual 
proteolytic activity is plotted against the concentration of trypsin inhibitor, a straight 
line  is obtained.  In determining the inhibitory activity of an unknown  solution, 
0.5 ml. quantities of appropriate dilutions of the sample were mixed with 0.5 ml. of 
the standard crystalline trypsin solution and incubated for 15 minutes.  The residual 
activity of the mixture is then  determined, and by interpolation on the  standard 
curve the inhibitory activity of the unknown can be expressed in terms of milligrams 
of the standard inhibitor preparation per milliliter of solution. 
10. Saline Buffer.--This consisted of the borax-borate mixture described  by Clark 
(1928, page 213), containing 0.9 per cent NaC1 and adjusted to pH 7.4. 
Determinations of pH were made with a glass electrode.  The temperature in all 
experiments was controlled  to ±  0.1°C.  Merthiolate 1:10,000 or 1:20,000 was used 
as a preservative in all organic solutions. 
EXPEP.IM~ENTAL 
Identity of Lysin Factor and Serum Protease 
Measurements of the pH of optimum activity, pH of maximum stability, 
and temperature-activity relationships were made in order to characterize the 
chloroform-activated serum  protease  and  fibrinolysin-activated  lysin  factor. 
Under  the  experimental conditions,  both  of  these  proteolytic enzyme prep- 
arations were found to be identical in these  respects. 
1.  pFl  of  Optimum  Activity.--Preparations  of  fibrinolysin-activated  lysin 
factor and chloroform-activated serum protease in saline buffer were adjusted 
to various pH values by the addition of HC1 or NaOH, brought to 35°C., and 
mixed with gelatin at the same pH.  The mixtures were immediately placed 
in  Ostwald  viscosimeters  and  the  proteolytic  activity  determined  by  the L.  R.  CHRISTENSEN  AND  C.  ~.  MACLEOD  563 
method described previously.  The data  obtained  in  these  experiments are 
plotted in Fig.  1. 
It is evident from Fig. 1 that the two systems are most active at the same 
pH, in a rather narrow range between pH 7.2 and 7.6, and both show the same 
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FIG. 1.  pH of optimum activity of fibrinolysin-acfivated  lysin factor and chloro- 
form-activated serum protease.  Activity is expressed in terms of proteolytic units, 
determined as described  in the section on methods. 
2.  pH of Maximum Stability.--In determining the pH of maximum stability 
of the  two proteases, solutions of the fibrinolysin-activated lysin factor and 
chloroform-activated serum protease in saline buffer were adjusted to the de- 
sired pH values with HC1 or NaOH and incubated at 45°C. for 30 minutes. 
At the end of this time they were removed, neutralized, adjusted to constant 
volume, brought to 35°C.  as  rapidly as possible,  and  tested for proteolytic 
activity against gelatin at pH 7.4.  45°C. was chosen as the inactivating tem- 
perature because the effects  were more rapid than at lower temperatures, permit- 564  PROTEOLYTIC  ~.NZYM~E  OF  SERU~ 
ring more observations to be made in a  given time.  The values obtained are 
shown  in Fig.  2. 
From the observations recorded in Fig. 2 it can be seen that at 45°C. both 
fibrinolysin-activated lysin  factor  and  chloroform-activated serum  protease 
have their maximum stability in a narrow range between pH 7.0 and 7.4, with 
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FIG. 2. pH of maximum stability of fibrinolysin-acrivated  lysin factor and chloro- 
form-activated serum  protease at 45°C.  Activity is expressed  in terms of proteo- 
lyric units, determined as described  in the section on methods. 
3.  Temperature-Activity  Relationships.--An Arrhenius plot of the temperature 
activity relationships of the two preparations was made.  In determining the 
activity values  for  the  Arrhenins  plot,  the  proteolytic activity  of  the  two 
preparations at the various temperatures was measured in the manner described, 
using gelatin at pH 7.4 as substrate.  The temperature of each determination 
was controlled to within :k: 0.1°C.  In Fig. 3 the logarithms of the activities 
of the two proteases at the various temperatures have been  plotted against 
the reciprocal of the absolute temperature. 
The slopes of the curves for the values obtained with fibrinolysin-activated L.  R.  CHRISTENSEN  AND  C.  ~.  MACLEOD  565 
lysin factor, as shown in Fig. 3, were calculated by the method of "least squares." 
Multiplication  of arbitrary points on these calculated curves by a  constant 
factor enables one to transpose  the  lysin factor curves to the experimental 
values  obtained  with  chloroform-activated serum  protease.  When  this  is 
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Fzo. 3.  Arrhenius  plot of fibrinolysin-activated  lysin factor and chloroform-acti- 
vated serum protease.  Activity is  expressed  in terms  of proteolytic units,  deter- 
mined as described in the section on methods. 
quite  well,  indicating  that  the  Arrhenius  plots  of the  two preparations are 
identical.  This calculation would appear to be valid because the slopes of an 
Arrhenius plot are  independent of the  units employed or the  concentration 
of the enzyme, provided the units used are directly proportional to the enzyme 
concentration. 
The Arrhenius plots presented in Fig. 3 indicate that the optimum temper- 
ature for the two preparations is about 37°C., as shown by the sharp change in 
direction of the plots at this point.  Above 37°C. the activity decreases, pos- 566  PROTEOLYTIC ENZYME  OF SERU]~ 
sibly due to heat denaturation of the enzyme.  A marked increase in the rate 
of inactivation is shown  by both preparations as  the  temperature  is raised 
above 53°C.  The exact significance of this second break in the curve is not 
known;  however, Sizer  (1944)  has  recently reported  a  similar  break  in  an 
Arrhenius  plot  of  catalase. 
It is possible to calculate the energy of activation and energy of inactivation 
of an enzyme from the slopes of an Arrhenius plot (Sizer, 1943).  Calculation 
of these constants from the calculated slopes of the activated lysin factor plot 
indicates that the heat of activation is about 14,000  to 16,000  calories.  The 
energy of inactivation in  the region between 37 ° and 53°C.  is about 50,000 
calories, and  in the  region above 53°C.  the energy of inactivation  is about 
400,000 calories.  Because of inherent errors in the methods used, these figures 
are  only approximations of the  true values.  For example, the viscosity of 
gelatin  is  not  a  regular  function  of temperature,  nor does  the  viscosity of 
gelatin  remain  constant  at  higher  temperatures  in  the  absence  of enzyme. 
Further, when gelatin is used as substrate, viscosity measurements cannot be 
made  with  any accuracy below  a  temperature  of  30-32°C.  Despite  these 
sources of error, the energies of activation and inactivation are of the order 
of magnitude  of many enzymes  (Sizer,  1943). 
The close similarity between fibrinolysin-activated lysin factor and chloro- 
form-activated serum protease in respect to the effects of pH and temperature 
on their activity leaves little doubt that the two are very similar if not identical. 
In  subsequent  portions  of  the  present  paper,  therefore,  the  term  "serum 
protease"  will be  used  to  designate  the  proteolytic activity of  serum,  and 
unless otherwise specified will indicate fibrinolysin-activated material. 
Activation  of Serum Protease by Fibrinolysin 
A study of the fibrinolysin activation of serum protease is accompanied by 
certain difficulties.  Of these, the most important is that caused by the presence 
of variable amounts of serum  inhibitor in  the  serum protease preparations, 
resulting  in an apparent alteration  in  the  course of the  activation reaction. 
Furthermore, since no method has been found of destroying or inactivating 
fibrinolysin without at the same time destroying serum protease, some further 
activation of serum protease occurs during the period of testing for liberated 
serum protease activity.  For these reasons the values obtained in the present 
study are only approximations of the true values. 
These  difficulties were  minimized  as  much  as  possible  by  studying  the 
activation of a sample of serum protease which contained only a small amount 
of  serum  inhibitor.  The effect of continued activation  during  testing  was 
minimized  by  activating  with  dilute  solutions of  fibrinolysin,  so  that  the 
further 14-fold dilution of the fibrinolysin which  occurs  during  the  determi- 
nation of proteolytic activity of the mixture would lower the concentration of 
fibrinolysin below an effective level. L.  R.  CHRISTEN'SEN  AND  C.  M.  MACLEOD  567 
1.  Activation  of Serum  Protease  by  Fibrinoly~in  in  the  Presence  of Serum 
Inhibitor.--Kunitz  (1938)  has  shown  that  the  formation  of  trypsin  from 
trypsinogen by the mold kinase follows the course of a catalytic unimolecular, 
or first order reaction, which may be expressed by the equation 
Ae 
log  Ae  --  A  (KM)t 
where Ae is the trypsin activity after complete activation, A is the concentra- 
tion of active trypsin in the activation mixture at any time t, and (KM) is the 
slope of the straight line obtained when the values of 
As 
log As- A 
are plotted against the values for t. 
In testing the activation of serum protease, aliquots of inactive serum pro- 
tease preparations (lysin factor) were mixed with equal volumes of dilutions 
of a  fibrinolysin concentrate and incubated at  25°C.  in a  water bath.  At 
intervals, 1 ml. of the mixture was removed and tested for proteolytic activity. 
Two serum protease preparations were used in this study.  Both had the same 
amount of proteolytic activity when treated with an excess of fibrinolysin; 
3.0 proteolytic units per ml. of activation mixture.  Preparation 514 contained 
serum inhibitor equivalent to 0.001 rag. per ml. of the standard trypsin inhibitor 
preparation,  as  determined  by  the  procedure  described  in  the  section  on 
methods.  The  second preparation,  No.  598,  contained inhibitor equivalent 
to 0.0047 rag. per ml.  The data obtained in these experiments were analyzed 
by means of the equation used by Kunitz (1938)  and the results plotted in 
Fig.  4. 
It is evident from Fig. 4 that the activation of serum protease preparation 
514,  containing the least amount of inhibitor, is a  linear function of the time 
of incubation, indicating a first order reaction (Kunitz, 1938).  With the high- 
est dilutions of fibrinolysin, 1: 400 and 1: 500, the curves deviate somewhat from 
a  linear relationship, prohably due to  the  action of serum  inhibitor on the 
smallamount of free enzyme which would be present at any time in the mixture. 
This conclusion is borne out by the results obtained with the second serum 
protease preparation, No. 598, which contains about 5 times as much inhibitor 
as preparation 514.  In this case a  linear relationship is not obtained, even 
with the  higher concentrations of fibrinolysin. 
It is apparent from the above data, therefore, that the kinetics of fibrinolysin 
activation of serum protease is not that of a first order reaction in the presence 
of serum inhibitor.  However, as the concentration of inhibitor decreases, the 
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activation  of  the  serum  protease  by  fibrinolysin,  analogous  to  the  kinase 
activation of trypsinogen. 
2.  Effect of Fibrinolysin Concentration  on Rate of Activation.--In Fig. 4  the 
slopes of the lines are proportional to the rate of  activation (Kunitz, 1938).  In 
Table I  are presented the slopes of the activation curves of serum protease 
preparation  514  when  activated  by  varying  concentrations  of  fibrinolysin, 
calculated  from  the  data  presented  in  Fig.  4. 
From the calculations shown in Table I  it can be seen that the slopes of the 
activation curves of the serum protease preparation are directly proportional 
to the concentration of fibrinolysin, except in the case of the more dilute prep- 
arations of fibrinolysin.  The lack of proportionality in these cases is probably 
due to the presence of serum inhibitor in the sample, as has been discussed 
above.  This is borne out by the fact that in the presence of higher concentra- 
TABLE I 
Effect of Fibrinolysin Concentration on the Rate of Activation of Serum Protease 
Fibrinolysin concentration  Slope of activation curve* 
1:100  0.065 
1 :  200  0.0325 
1:400  0.015 
1:500  0.006 
* The slope of the curve is a measure of the rate of activation. 
tions of serum inhibitor than are present in preparation 514 (e.g. preparation 
598), the rates of activation are not proportional to the fibrinolysin concentra- 
tion, even when higher concentrations of fibrinolysin are used.  On the other 
hand, with low concentrations of serum inhibitor the activation rates are more 
nearly proportional to  the  concentration of fibrinolysin.  It  appears  highly 
probable, therefore, that in the absence of serum inhibitor, the rate of activation 
of serum protease by fibrinolysin would be directly proportional to the con- 
centration of fibrinolysin, suggesting an enzymatic type of activation. 
3.  Temperature Coe~cient of Activation.--The temperature coefficient of the 
activation  reaction  was  determined  by  mixing  aliquots  of  serum  protease 
preparation  514 with equal volumes of a  1:200  dilution  of fibrinolysin and 
incubating the mixtures at 25°C. and 35°C.  At intervals, 1 ml. of the mixture 
was  removed and  tested  for proteolytic activity.  The results obtained are 
plotted in Fig. 5 in the same manner as in the previous experiment, using the 
equation of Kunitz  (1938). 
Calculation of the slopes of the curves in Fig. 5 reveals that an increase in 
temperature of 10°C. between 25  ° and 35°C. results in an increase of 1.76-fold 
in  the  rate  of activation,  indicating  that  the  temperature  coefficient of  the 
reaction between these temperatures is about 1.8. 570  PROTEOLYTIC ENZYME  OF SERD~ 
The data  obtained in the above experiments are compatible with the hy- 
pothesis that the activation of serum protease by fibrinolysin is an enzyme- 
catalyzed reaction.  The kiuatics of activation is those of a first order reaction 
with the rate of activation directly proportional to the fibrinolysin concentra- 
tion and  the  temperature  coefficient of the  reaction about  1.8  between  25  ° 
and 35°C.  In the presence of serum inhibitor, however, the reaction appears 
to  be  complicated  by combination  of active enzyme with  inhibitor,  which 
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Fxo. 5. The effect of temperature on the rate of activation of serum protease by 
streptococcal fibrinolysin. 
Interaction of Serum Protease and Inhibitors 
Following the  demonstration that  the  activation  of serum protease  is an 
enzymatic type of reaction, it became of interest to determine the mechanism 
of activation.  Mention has been made in the introduction to this paper of the 
hypothesis that serum protease is normally inactive in serum because of the 
presence of serum inhibitor. 
1.  Nature  of  Serum  Protease  Inhibition  by  Crystalline  Trypsin  Inhibitor 
and  Serum  Inhibitor.--Northrop  and  his  coworkers have  shown  that  both 
pancreatic trypsin  inhibitor and  serum inhibitor combine with trypsin, and 
that the kinetics of the reaction indicate the formation of an equimolar, dis- L.  R.  CIIRISTENSEN  AND  C.  M.  MACLEOD  571 
sociable, inhibitor-enzyme compound (Northrop, 1939; Kunitz and Northrop, 
1936; Hussey and Northrop, 1923).  In order to determiae whether or not the 
inhibition of serum protease is of similar nature, the inhibition of activated serum 
protease by crystalline pancreatic trypsin inhibitor and by serum inhibitor was 
compared with the effect of these agents on crystalline trypsin. 
Fibrinolysin-activated serum  protease  was  mixed  with  equal volumes  of 
crystalline trypsin inhibitor solution of varying concentration  s .  The mixtures 
were incubated at 35°C. for 10 minutes to allow combination, and 1 ml. of the 
mixture was then tested for residual proteolytic activity against gelatin.  A 
trypsin solution containing 0.01  mg. per ml. of the crystalline trypsin prep- 
aration was tested with inhibitor solutions in the same way.  This concen- 
tration of trypsin was chosen because it possessed about the same proteolytic 
activity under the conditions of the present experiment as the activated serum 
protease preparations.  The results of these experiments are plotted in Fig. 6. 
The curve drawn through the values obtained for the inhibition of trypsin was 
recalculated from the data of Northrop (1939, p. 11) on the inhibition of trypsin 
by trypsin inhibitor. 
It is evident from the observations shown in Fig. 6 that the reaction between 
serum  protease  and  crystalline trypsin  inhibitor differs markedly from  the 
reaction of trypsin with the inhibitor.  Not only is the inhibitor much less 
active against serum protease than against trypsin, but the shapes of the two 
inhibition curves are so different as to suggest a marked qualitative difference in 
the inhibition of the two enzymes by crystalline trypsin inhibitor. 
The experiment described above was repeated except for the substitutio~ of 
serum inhibitor for the crystalline trypsin inhibitor, although available evidence 
suggests they are the same substance (Schmitz, 1938; Grob, 1943).  The results 
are plotted in Fig. 7, with the curve drawn through the values obtained with 
trypsin recalculated from the  data  of Hussey and  Northrop  (1923) on the 
inhibition of trypsin by serum. 
The data recorded in Fig. 7 indicate the same qualitative and quantitative 
differences in the inhibition of serum protease and trypsin by serum inhibitor 
as were found in the experiments employing the crystalline trypsin inhibitor 
from the pancreas. 
Experiments have been carried  out with chloroform-activated serum pro- 
tease using the  two inhibitors.  The chloroform-activated protease behaved 
in the same manner as the fibrinolysin-activated material. 
It  is apparent,  therefore, that although both crystalline trypsin inhibitor 
from the pancreas and serum inhibitor affect the activity of serum protease, the 
reaction is not the same as when these inhibitors act on crystalline trypsin. 
2.  Effect of Fibrinolysin on Serum Protease  Inhibition.--It has been assumed 
by several investigators that serum protease is normally inactive because of the 
presence of serum inhibitor (Delezene and Pozerski, 1903; Yamakawa, 1918; 
Schmitz, 1937; Jiihling and WShlisch, 1938).  If this were correct it should be 572  PI~OTEOLYTIC  ENZYME  OF  SER~ 
possible to demonstrate an action of fibrinolysin on either the isolated inhibitor 
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Fro. 6.  Inhibition of serum protease and crystalline trypsin by crystalline trypsin 
inhibitor.  The concentrations of inhibitor used with trypsin are only ~  those used 
to inhibit serum protease.  The curve drawn through the values for crystalline trypsin 
was recalculated from data of Northrop (1939) and superimposed on the experimental 
points.  Activity is  expressed in terms of proteolytic units, determined as described 
in the section on methods. 
A sample of lysin factor was activated by adding a small amount of fibriaolysin solu- 
tion and allowing the mixture to stand at room temperature for several hours.  When 
activation was complete, the activated protease was salted out by the addition of 1/2 
volume of saturated  ammonium sulfate.  The precipitate  was collected  by centrif- 
ugation, washed  several  times with  1/3  saturated  ammonium sulfate solution, and 
reprecipitated.  It was then dialyzed sulfate-free and made up to the original volume L.  R.  CHRISTENSEN AND C.  M.  MACL~.OD  573 
in saline buffer.  This procedure was employed in order to reduce the residual fibfino- 
lysin concentration of the solution as much as possible. 
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FzG.  7.  Inhibition of serum protease and crystalline trypsin by serum inhibitor. 
The mounts of serum inhibitor (albumin solution) used to inhibit crystalline trypsin 
are -~ those used to inhibit serum protease.  The curve drawn through the values 
obtained for crystalline trypsin was recalculated from data of Hussey and Northrop 
(1923)  on the inhibition of trypsin by serum, and was superimposed on the exper- 
imental  points.  Activity is expressed in terms of proteolytic units, determined as 
described in the section on methods. 
In testing the effect of fibrinolysin on  the inhibition of  the activated protease, 
a series of tubes was set up, each containing 0.5 ml. of activated protease, 0.5 ml. of a 
solution of  crystalline trypsin inhibitor, and  0.1  ml.  of dilutions of a  fibrinolysin 
concentrate.  The mixtures were incubated at 35°C. for 10 minutes and tested for 
residual proteolytic activity.  Control tubes contained respectively serum protease 
alone, serum protcase with inhibitor, and serum protease with fibrinolysin.  In order 574  PROTEOLYTIC  ENZYME  OF  SERU~ 
to avoid an excess of inhibitor, the amount of crystalline inhibitor used was insufficient 
to inhibit the protease completely.  The results of this  experiment are  shown in 
Table II. 
As shown  in Table II, under  the experimental conditions employed fibrin- 
olysin did  not  increase  the activity of the partially inhibited protease.  The 
lack of an activating effect of fibrinolysin does not appear to be due to in- 
sufficient fibrinolysin since it was observed repeatedly that the same fibrinolysin 
preparation was capable of activating completely within 10 minutes all lysin 
factor preparations with which  it was  tested. 
TABLE II 
Effect  of Fibrlnolysin  on the Inhibition of Serum Protease by Crystalline Pancreatic 
Trypsin Inhibitor 
Residual activity after incubation in proteolytic units 
Inhibitor 
concentration  Concentration of fibrinolysin 
I:I00  I:  I000 
rag. per ml. 
o 
0.02 
0  I:I0 
1.66  1.20 




Effect of Fibrinolysin  on Inhibition of Serum Protease by Serum Inhibitor 
Residual activity after incubation in proteolytic units 
Inhibitor  concentration  Concentration of fibrinolysin 
0  1:10  l:lO0  1:1000 
ml. of albv/~in 
0  1.66  1.20  1.42  1.60 
0.2  1.3  1.02  1.37  1.45 
0.5  0.9  0.72  0.77  0.78 
It can also be seen from the data shown in Table II that the fibrinolysin 
solutions, rather than  increasing the  activity of the  partially inhibited pro- 
tease, actually caused a  decrease in the residual activity, suggesting the pres- 
ence  of  an  inhibitor of proteases in the fibrinolysin solution itself.  Such an 
inhibitor of proteases could be demonstrated in fibrinolysin preparations by 
adding them to trypsin solutions. 
The experiment described above was repeated except for the substitution of 
serum inhibitor for crystalline trypsin inhibitor.  The results of this experiment 
are shown in Table III. 
As in the previous experiment, the data presented in Table III indicate that 
fibrinolysin does not increase the activity of the partially inhibited protease. L.  R.  C'~H~ISTENSEN  AND  C.  ]~g° ~rACLEOD  575 
Likewise, it appears that the fibrinolysin solution itseff caused some inhibition 
of the protease. 
A  number of variations of these experiments has been carried out.  Incu- 
bation of fibrinolysin and inhibitor before addition of the protease was found 
to be without effect on the degree of inhibition.  Furthermore, incubation of 
the protease and inhibitor, or protease and fibrinolysin before the addition of 
the third reagent was likewise without effect on the degree of inhibition.  Chlo- 
roform-activated protease behaved in the same way as the fibrinolysin-activated 
material, that is, fibrinolysin did not decrease the amount of inhibition caused 
by either inhibitor. 
It has also been found that the  inhibition of crystalline trypsin by either 
serum or pancreatic inhibitor is not influenced by the presence of fibrinolysin in 
the reaction  mixture, although  again  the  fibrinolysin  solutions  inhibit  the 
proteolytic activity of the trypsin to some extent. 
It  appears,  therefore,  that  streptococcal fibrinolysin  is  entirely  without 
effect on the inhibition of serum protease by serum or pancreatic inhibitors. 
Furthermore, since fibrinolysin is capable of activating serum protease from 
its normal inactive state in serum, ~t follows that this inactive state of serum 
protease is not due to combination of the protease with serum inhibitor, but to 
some  other mechanism. 
Substrate  Specificity  of Serum  Protease  and  Trypsin 
The reactions of serum protease and  trypsin with protease  inhibitors,  to- 
gether with the characteristics of serum protease as described in a previous 
section  of the  present  paper,  suggest  that  serum  protease and  trypsin are 
dissimilar  enzymes. 
Northrop (1939, p. 76) has shown that when an enzyme is allowed to act on a 
protein substrate  until hydrolysis has virtually ceased, addition of a  second 
quantity of the same enzyme does not result in further hydrolysis.  On the 
other hand,  if a  different enzyme is added, further hydrolysis  of the substrate 
takes  place.  This  phenomenon  is  probably  an  expression  of  the  different 
peptide  bond  specificities of  the  two  enzymes,  since,  as  Bergmann  and  his 
coworkers (1941,  1942)  have shown, each proteolytic enzyme is characterized 
by the ability to hydrolyze certain specific peptide linkages.  In Northrop's 
experiment,  therefore, once all of the  bonds  susceptible  to  one enzyme are 
split, no further action can be produced by this enzyme although further hy- 
drolysis will occur on the addition of an enzyme having different specificities. 
In order to determine whether or not the serum enzyme and trypsin attack the 
same linkages of the substrate molecule, 20 ml. allquots of a 5 per cent casein solution 
were mixed with 5 ml. portions of a solution of either serum protease or trypsin.  At 
intervals, 1 ml. portions of the mixtures were removed, precipitated with trichloracetic 
acid, and the acid-soluble tyrosine in the filtrate determined by a method outlined in 
a  previous paper (Christensen,  1945).  The following  day, when the rate of acid- 576  PROTEOLYTIC  ENZYMIE  OF  SERUM 
soluble  tyrosine liberation had dropped to nearly zero, the reaction mixtures were 
divided into three portions.  In one portion the rate of acid-soluble tyrosine liberation 
was followed without the addition of Other reagents; to the second portion was added 
a second quantity of the enzyme first used; to the third portion of the reaction mixture 
containing trypsin, serum protease was added, and to the reaction mixture containing 
serum  protease, trypsin was  added.  The results obtained in  this experiment are 
plotted in Fig. 8, where the milligrams of acid-soluble tyrosine liberated per milliliter 
of reaction mixture are plotted against the incubation time. 
It is evident from the data presented in Fig. 8 that serum protease rather 
quickly liberates from casein the majority of the acid-soluble tyrosine which 
it is capable of liberating and addition of fresh enzyme does not result in any 
further increase.  However, if trypsin is added to the serum protease digest, 
a prompt and marked rise in acid-soluble tyrosine liberation occurs, indicating 
that  linkages  are still  available  for the action  of trypsin after all those sus- 
ceptible to serum protease have been split.  On the other hand,  if casein is 
first digested by trypsin, addition of serum protease to the digest mixture does 
not result in further hydrolysis of the casein, although the increase in acid- 
soluble tyrosine on addition of more trypsin indicates that hydrolysis by tryp- 
sin is not yet complete.  This might be taken as an indication that trypsin is 
able to hydrolyze not only the linkages split by serum protease, but others as 
well.  In any case, it is evident that trypsin is able to continue hydrolysis of 
casein after hydrolysis by serum protease has gone to completion. 
DISCUSSION  AND  SUMM-~¥ 
The  observations  recorded  in  the  present  paper  indicate  that  the  lysin 
factor described by Milstone (1941) and the chloroform-activated serum pro- 
tease are one and the same proteolytic enzyme, differing only in their mode of 
activation.  The serum protease is most stable at a  pH near 7.2, and its pI-I 
of optimum activity is also in this region.  The pH of optimum activity may 
be not so much a reflection of the pH at which the individual molecules of the 
enzyme are most active, but instead be related to the marked instability of the 
enzyme above and below this pH range.  The Arrhenius plot of the tempera- 
ture-activity characteristics of the enzyme indicates that the optimum tem- 
perature for activity is about 37°C.  Above this temperature activity falls off 
rapidly,  probably  due  to  heat  inactivation.  A  second  sharp  break  in  the 
Arrhenius plot occurs at a temperature of about 53°C., above which point the 
activity of the enzyme decreases with great rapidity.  This type of two-phase 
inactivation curve for an enzyme has recently been discussed by Sizer (1944) 
in relation to a similar phenomenon which occurs with catalase.  The energies 
of activation and inactivation of the enzyme, as calculated from the slopes of 
the Arrhenius plot, are only approximations because of certain errors inherent 
in  the  methods  used.  However,  the  values  obtained,  16,000  calories  and 
50,000 calories respectively, are of the order of magnitude characteristic of most 
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FIG. 8. Combined action of serum protease and trypsin  on casein.  The upper portion 
of the figure represents the hydrolysis of casein by trypsin, followed by the addition of 
fresh trypsin soIutlon  (containing  0.5 mg.  of the dry material per ml.) and serum 
protease solution (containing about 2.8 proteolytie  units per rot.).  The lower portion 
of the figure  represents the  hydrolysis of casein  by serum protease solution  (2.8 
proteolytic units per ml.), followed by the addition of fresh serum protease solution 
and by trypsin solution (0.5 mg. per ml.).  Activity is expressed in terms of pro- 
teolytic units, determined as described  in the section on methods. 
is higher than the values recorded by Sizer (1943) for most other enzymes. 
The actual value is subject to some error, but the order of magnitude for the 
inactivation energy of  serum  protease  above  53°C.  agrees  with  the  higher 
value found for catalase by Sizer (1944), namely 255,000 calories. 578  PROTEOLYTIC  ENZYME  O]~ SERI.r~ 
It seems apparent that serum protease  is not trypsin nor is it similar to 
trypsin in its properties, as has been implied previously (Schmitz, 1936, 1937; 
Iyengar,  1942;  Ferguson,  1939, 1940 a,  b;  Tagnon,  1942 a,  b).  Trypsin, in 
contrast to serum protease, does not exhibit as sharp a zone of maximal activity 
in the neighborhood of pH 7.4, with the marked drop in activity above and 
below this point that is shown by serum protease.  Crystalline trypsin is most 
stable at a  pH of about 3, but crude preparations are stable over a  range of 
about pH 6-8.  Since the serum protease preparation is quite crude, it is not 
possible to state that the two enzymes differ in this respect. 
Other evidence of the non-identky of the two er~ymes, trypsin and serum 
protease,  is brought out by the difference in behavior toward protease inhi- 
bitors.  Hussey and Northrop (1923), Kunitz and Northrop (1936), and Grob 
(1943) have shown that the kinetics of inhibition by either serum or pancreatic 
inhibitor indicates the reaction to be due to the formation of a  dissoclable, 
equimolar compound between enzyme and inhibitor.  The inhibition of serum 
protease by these two inhibitors, however, requires much more of either in- 
hibitor in order to inhibit the same amount of proteolytic activity than in the 
case of trypsin.  In addition to this marked quantitative difference, the shape 
of the inhibition curves of the two enzymes in the presence of either inhibitor 
differs so markedly as to indicate the possibility of a  different mechanism of 
inhibition.  Several explanations might be advanced for these differences in the 
inhibition of the  two enzymes.  It  is possible  that the  inhibition of serum 
protease is not an equimolar reaction, but that several molecules of inhibitor 
must combine with the enzyme before inhibition is complete.  It is also pos- 
sible  that  trypsin  is  more  actively proteolytic per  molecule than  is  serum 
protease, or it is possible that the dissoc~tion of the serum protease-inhibitor 
complex differs greatly from that of the trypsin-inhibitor complex. 
The identical behavior of both the serum and pancreatic inhibitors toward 
both trypsin and serum protease furnishes additional evidence that the two 
inhibitors are very similar if not identical, as postulated by Schmitz (1938). 
Further evidence as to the non-identity of the two enzymes is shown in the 
study of their combined effect on a single substrate.  The data indicate quite 
clearly that trypsin is able to continue the hydrolysis of casein after hydrolysis 
by serum protease is practically complete.  In the light of the work of Berg- 
mann (1941,  1942) and his coworkers on the peptide bond specificity of pro- 
teases, this may be interpreted as indicating that serum protease and trypsin 
split different linkages in the substrate molecule.  When the converse of this 
experiment was carried out, that  is,  when trypsin was allowed td act first, 
followed by serum protease, no further hydrolysis took place, even though the 
action of trypsin was not complete, as indicated by further hydrolysis on the 
addition of more trypsin.  In explaining these findings it may be suggested 
that the linkages split by serum protease are among those split by trypsin and L. R. CIlRISTENSEN AND  C. M. ~fAcLEOD  579 
that the latte  r enzyme is able to split additional linkages.  It is also possible 
that  the  linkages  split  by serum protease  are  contained  in  the  acid-soluble 
fragments of trypsin digestion,  and  under  the  conditions of  the  experiment 
it is not possible to detect the hydrolysis of these bonds by serum protease. 
In any event, it is apparent that trypsin is able to split linkages in casein which 
serum  protease  cannot. 
It has not been possible in any experiment so far devised to demonstrate 
that fibrinolysin affects in any way the inhibition of serum protease or of trypsin 
by  either  serum  or  pancreatic  inhibitors#  It  appears,  therefore,  that  the 
normal inactive state of serum protease in the serum is not due to the inhibitor 
also present  in  the  serum,  but  involves some  other mechanism.  It is inte- 
resting to note that prior to the studies of Kunitz and NOrthrop the inactivity 
of  pancreatic  extracts  was  explained  on  the  basis  that  the  proteases were 
combined  with  the  inhibitor  also  present  in  the  same  extracts  (Northrop, 
1939).  Kunitz  and  Northrop  (1936)  demonstrated  that  these  enzymes are 
inactive because they occur in a  precursor or zymogen state from which they 
can be activated by certain specific activators (kinases) and in some cases by 
non-specific  agents  such  as  magnesium  and  ammonium  sulfate.  Following 
activation from the precursor state, the active enzymemay then combine with 
inhibitor  with  resulting  loss  of  activity. 
While  it has not been possible to demonstrate an action of fibrinolysin on 
serum protease inhibited by either serum or pancreatic trypsin inhibitors,  it 
has been shown that the activation of serum protease from its normal state in 
serum by fibrinolysin is apparently a  catalytic reaction.  The kinetics of this 
reaction, in the absence of large amounts of serum inhibitor, indicates that it is 
enzymatic in character, as is the kinase activation of the pancreatic proteases. 
4 Mirsky  (1944) has  recently  reported  inhibition of  the fibrinolytic activity of 
streptococcal  cultures  by addition  of  crystalline  trypsin  inhibitor  of  Kunitz  and 
Northrop (1936) and the inhibitor extracted from soybeans by Ham and Sandstedt 
(1944).  Mirsky suggests  that inhibition  is  due  to  inactivation  of fibrinolysin  by 
inhibitors and that fibrinolysin is a protease related to trypsin.  The apparent contra- 
diction between the results presented in the present paper and  those  obtained  by 
Mirsky would appear to be based on differences in the amounts of inhibitor used.  A 
satisfactory method for the measurement of the small amount of proteolytic activity 
in unconcentrated serum has not been available to us, but based on estimates of the 
proteolytic activity of unconcentrated serum, and the amount of crystalline trypsin 
inhibitor necessary to inhibit the serum protease concentrates, it appears that Mirsky 
used levels of trypsin inhibitor 100-500 times as high as would be necessary to com- 
pletely inhibit all of the serum protease activity in his fibrinogen preparations.  Thus, 
even though fibrinolysin was added to the mixture, the tremendous excess of inhibitor 
would  result in inactivation of serum protease as rapidly as it was activated.  The 
results obtained by Mirsky, therefore, are probably due to inhibition of the activated 
protease by an excess of inhibitor rather than to inhibition of fibrinolysin. 580  PROTEOLYTIC  ENZY~E  OF  SERITM 
The rate of activation is directly proportional to the fibrinolysin concentration 
and  the  activation has  a  temperature  coefficient of about  1.8.  Following 
activation by fibrinolysin,  the active protease may be inhibited by serum or 
pancreatic trypsin inhibitor, but as noted above, this inhibition cannot be in- 
fluenced by fibrinolysin.  In the presence  of serum inhibitor,  the kinetics of 
serum protease  activation is  complicated  by combination of the activated 
enzyme with inhibitor, causing the course of the reaction to deviate from that 
of a  first order reaction.  Northrop  (1939) has shown  that the kinetics of 
activation of pepsinogen  and trypsinogen also  shows a  deviation from the 
theoretical in the presence  of inhibitors of these enzymes. 
Serum protease may also be activated by chloroform and other non-specific 
agents.  The mechanism of activation by these agents requires further study. 
It is possible that one of two or more mechanisms is involved.  Bodine and 
his  coworkers  (1937, 1938, 1943, 1944) have  shown  that  treatment  with 
certain denaturing agents, such as chloroform or certain detergents, activates 
the  protyrosinase  of  grasshopper  eggs.  Activation  apparently  involves 
slight  denaturation  of  the  proenzyme  protein.  On  the  other  hand,  the 
function of chloroform in the activation of serum protease may be the removal 
of serum inhibitor, allowing spontaneous activation of the protease, analogous 
to the spontaneous activation of trypsinogen which occurs in the absence  of 
trypsin  inhibitor.  Certain  evidence  supporting  this  latter  hypothesis  is 
available in the case of serum protease.  Teale and Bach (1919) have shown 
that serum inhibitor can be removed from serum by organic  solvents only 
when coagulation of protein occurs.  In this laboratory it has been noted 
that solutions of inactive serum protease (lysin factor) which contain little 
or  no  serum  inhibitor may become  active  spontaneously on  standing for 
several weeks in the refrigerator (Christensen,  1945).  It is possible, therefore, 
that chloroform treatment of serum results in the removal of serum inhibitor 
by producing protein denaturation.  Upon removal of the  inhibitor, spon- 
taneous  activation  of  the  serum  protease  may  occur.  This  spontaneous 
activation may be  autocatalytic in  nature.  The  proteolytic enzyme pre- 
cursors  pepsinogen  and  trypsinogen  are  autocatalyticaUy activated  with 
great  rapidity, which  is  apparently not  true  of  serum  protease.  On  the 
other hand, chymotrypsinogen shows some spontaneous activation, but the 
process  is much slower than with pepsinogen  and trypsinogen (Kunitz and 
Northrop, 1935). 
The  data  obtained in  the  present  experiments are  compatible with the 
hypothesis that the proteolytic enzyme system of serum is analogous to the 
proteolytic enzyme  systems of  the  pancreas,  trypsin  and  chymotrypsin. 
The serum enzyme occurs normaUy in serum and plasma in an inactive pre- 
cursor  state,  similar  to  trypsinogen  and  chymotrypsinogen.  Activation 
from this precursor state can be accomplished by treatment with strepto- 
coccal fibrinolysin,  which acts in a manner analogous to enterokinase or the L. R. CHR,ISTENSEN AND  C. M. MACLEOD  581 
mold kinase of Kunitz (1938).  Activation may also be produced by other 
means, the mechanism of which is not yet understood, but which may involve 
autocatalytic  activation.  Following  activation,  the  active  enzyme,  in 
common  with  trypsin,  may be  inhibited  by crystalline  pancreatic trypsin 
inhibitor or an inhibitor present in serum. 
Study of the properties of serum protease suggests that a  revisedtermino- 
logy should be introduced in order  to  describe it more  adequately.  Terms 
such as "serum trypsin" and  "serum  tryptase" are unsuitable  because  they 
imply a  relationship  between  the  serum  protease  and  trypsin.  The  data 
recorded in  the  present  paper  indicate  that  these  enzymes are  dissimilar. 
The older terms "fibrinolysin"  and "serum fibrinolysin" are also unsuitable 
because  the  enzyme is active against  proteins other  than  fibrin.  "Serum 
protease" is not completely satisfactory because it is binomial and also because 
the term "serum proteasogen" to indicate the zymogen form is cumbersome. 
Since the proteolytic enzyme of serum appears  to be analogous  to that  of 
certain of the pancreatic proteases, a  nomenclature based on the principles 
employed in designating the latter enzymes is suggested.  Under this scheme 
the activated enzyme may be termed "plasmin" in comformity with common 
usage  for proteases,  where  the  prefix indicates  the  source  of  the  enzyme, 
followed by -in, as with  "bromelin," "ficin," and "papain."  The inactive 
enzyme as it occurs in serum and plasma may be designated as "plasminogen" 
to indicate its source, the plasma, and also to indicate that it is in an inactive, 
precursor state.  Streptococcal fibrinolysin, also a  misnomer in the light of 
present knowledge,  may be  termed "streptokinase,"  analogous  to "entero- 
kinase" or "mold kinase."  The term "plasmin" has been used in the past 
to designate a fraction of blood obtained by a  special salting-out procedure. 
This usage,  however, has  become obsolete and  the  possibility of confusion 
with  the  proteolytic enzyme system  is  remote. 
CONCLUSIONS 
1.  Fibrinolysin-activated  lysin  factor  and  chloroform-activated  serum 
protease of serum and plasma are one and the same enzyme, differing only 
in  their  mode  of  actNation. 
2.  The enzyme as  it normally occurs in  serum or plasma  is not inactive 
because  of combination with serum inhibitor.  It  is present as an inactive 
precursor or zymogen and may be activated from this state by streptococcal 
fibrinolysin. 
3.  The  activation  of  serum  protease  by  streptococcal  fibrinolysin  is  a 
catalytic  reaction,  analogous  to  the  kinase  activation  of  trypsinogen by 
enterokinase.  Treatment of serum  or plasma  with  chloroform  apparently 
results in removal of serum inhibitor which may allowautocatalytic activation 
of the serum protease. 
4.  The serum enzyme differs from trypsin in its pH of optimum  activity, 582  PROTEOLYTIC ENZYME  O~" SERUM 
in its reactions with specific protease inhibitors, and in its action on casein. 
5.  A revised nomenclature for the serum enzyme system is suggested which 
more accurately describes its properties than the terms in current use. 
We are grateful to Dr. J. H. Northrop for suggestions during  the course of this 
work. 
We wish to acknowledge the invaluable technical assistance of Mrs. J. Fuld through- 
out  this  study. 
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